Pancreatic Disease Research and Personalized Medicine in Adults
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: closed (1 July 2022) | Viewed by 3370
Special Issue Editor
Special Issue Information
Dear Colleagues,
The incidence of pancreatic malignancies is increasing over the past years. However, benign diseases of the pancreas are more often being diagnosed and many clinicians are faced with an increasing number of patients with pancreatic diseases. The improvement of conventional treatment methods and the application of new therapies are the key to improving efficacy. Therefore, precision medicine is applied to pancreatic diseases. The diagnosis and treatment of the disease are particularly important.
This Special Issue focuses on the experimental research, diagnosis, and treatment of pancreatic diseases in adults.
Conventional treatment methods, including chemotherapy, are even nowadays mostly only palliative; the mortality rate has not decreased in the past decade, despite improvements. Recently, there have been many advances in the pathological research of pancreatic tumors, genomics, and transcriptomics. Artificial intelligence technology is also developing rapidly in the management of pancreatic diseases, guiding precision medicine in clinical, endoscopic, and radiological environments.
We search for papers dealing with experimental approaches reflecting pancreatic diseases but also for papers dealing with new insights in diagnosis of pancreatic diseases as well as therapeutic measures. We welcome both studies for benign and malignant pancreatic diseases.
Prof. Dr. Falk Rauchfuss
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreas carcinoma
- neuroendocrine tumor
- pancreas resection
- pancreatitis
- rare diseases
- animal experiments
- cell culture
- precision medicine
